Frankfurt - Delayed Quote EUR

Sedana Medical AB (publ) (7D2A.F)

1.2220
+0.0700
+(6.08%)
As of 9:17:23 AM GMT+2. Market Open.
Loading Chart for 7D2A.F
  • Previous Close 1.1520
  • Open 1.2000
  • Bid 1.2240 x --
  • Ask 1.2920 x --
  • Day's Range 1.2000 - 1.2220
  • 52 Week Range 0.5790 - 2.3900
  • Volume 5,500
  • Avg. Volume 94
  • Market Cap (intraday) 131.47M
  • Beta (5Y Monthly) 0.85
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0500
  • Earnings Date Jul 18, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care; and AnaConDa, a medical device enabling the administration of inhaled anaesthetics. It also provides FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; scavenging tube, a one-piece pre-connected tube designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; FlurAbsorb mount to hold the FlurAbsorb during scavenging of anaesthetic gas; FlurAbsorb-S mount to hold the FlurAbsorb-S during scavenging of anaesthetic gas; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to FlurAbsorb/FlurAbsorb-S; and Mindray exhaust connector, which enables connection of the exhaust of the ventilator to an active or passive scavenging system. In addition, the company offers AMG-06 Gas Monitor for continuous non-invasive sidestream monitoring of CO2 and anaesthetics concentration in inspired and expired gases; Sedaconda Filling Adapter, a single-use device for safe and easy extraction of isoflurane from a Sedaconda bottle to a Sedaconda Syringe; and a single-use standard iso/sevo adapter that is designed to fit standard threaded isoflurane and sevoflurane bottles. Further, it provides DRYLINE II and WaterLock 2 water traps, Nafion dryer tubing, respiratory gas monitoring lines, and gas sampling line H products. The company was founded in 1999 and is headquartered in Danderyd, Sweden.

www.sedanamedical.com

113

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 7D2A.F

View More

Performance Overview: 7D2A.F

Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .

YTD Return

7D2A.F
27.69%
OMX Stockholm 30 Index (^OMX)
1.43%

1-Year Return

7D2A.F
31.66%
OMX Stockholm 30 Index (^OMX)
4.04%

3-Year Return

7D2A.F
57.98%
OMX Stockholm 30 Index (^OMX)
25.22%

5-Year Return

7D2A.F
78.47%
OMX Stockholm 30 Index (^OMX)
65.41%

Compare To: 7D2A.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7D2A.F

View More

Valuation Measures

As of 5/12/2025
  • Market Cap

    123.94M

  • Enterprise Value

    109.26M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.67

  • Price/Book (mrq)

    1.34

  • Enterprise Value/Revenue

    6.36

  • Enterprise Value/EBITDA

    72.45

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -29.22%

  • Return on Assets (ttm)

    -2.87%

  • Return on Equity (ttm)

    -5.70%

  • Revenue (ttm)

    187.43M

  • Net Income Avi to Common (ttm)

    -54.77M

  • Diluted EPS (ttm)

    -0.0500

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    165.13M

  • Total Debt/Equity (mrq)

    0.52%

  • Levered Free Cash Flow (ttm)

    -171.73M

Research Analysis: 7D2A.F

View More